Top brokers have named Mesoblast limited (ASX:MSB) and these ASX shares as sells for next week. Here’s why they are bearish…
The post Top brokers name 3 ASX shares to sell next week appeared first on Motley Fool Australia. –
Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.
Three sell ratings that caught my eye are summarised below. Here’s why top brokers think investors ought to sell these shares next week:
Ampol Ltd (ASX: ALD)
A note out of Goldman Sachs reveals that its analysts have retained their sell rating and $23.30 price target on this fuel retailer’s shares. According to the note, the broker was surprised to see Ampol, formerly known as Caltex, announce a $300 million share buyback. Given the tough operating environment and its Lynton refinery closure, Goldman was expecting the company to delay any capital returns. While this is a positive for shareholders, it feels its shares are overvalued at the current level. Particularly given the growing capital intensity of the business, which it sees as a risk to capital return expectations in the future. The Ampol share price ended the week at $30.63.
Mesoblast limited (ASX: MSB)
According to a note out of Canaccord Genuity, its analysts have retained their sell rating but increased the price target on this biotechnology company’s shares slightly to $1.68. This follows the announcement of a deal with global pharma giant Novartis which could be worth upwards of US$1.25 billion to Mesoblast in milestone payments. The broker appears to believe the company’s shares are materially overvalued at the current level. The Mesoblast share price was fetching $4.07 at Friday’s close.
Xero Limited (ASX: XRO)
Analysts at UBS have retained their sell rating and lowly $77.00 price target on this cloud-based business and accounting software platform provider’s shares. According to the note, the broker was surprised with Xero’s announcement of a US$700 million convertible notes offering last week. It believes this could be a sign that management is readying a major acquisition. Although this has the potential to be a positive, it continues to see its shares as expensive. The Xero share price ended the week at $133.76.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
- These were the best performing ASX 200 shares last week
- The Aussie dollar is near a 2-year high. Here’s what it means for ASX shares
- ASX 200 falls on Thursday
- Top brokers name 3 ASX shares to sell today
- The 13 ASX shares that could have doubled your money in 2020
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.